Skip to content

Chemed CHE Deferred compensation plan assets

Other financials

Income statement

See full
Revenue$657.5M+1.6%
Gross profit$215.8M-0.3%
Operating income$84.6M-10.7%
Net income$66.3M-7.6%
EPS (diluted)$4.84-0.4%

Balance sheet

See full
Cash & equivalents$16.9M-90.3%
Total debt$236.9M+63.3%
Total equity$848.0M-28.2%
Total assets$1.5B-11.0%

Cash flow

See full
Operating cash flow$88.2M+169%
CapEx$17.1M+28.9%
Free cash flow$71.1M+265%

Valuation

See full
Market cap$5.79B-42.3%
Enterprise value$6.01B-39.6%
P/E22.3×-10.2×
P/S2.3×-1.8×

Profitability

See full
Gross margin32.4%-2.4pp
Operating margin12.9%-2.7pp
Net margin10.2%-2.2pp
FCF margin14.8%+2.2pp

Returns & leverage

See full
Return on equity25.6%-0.5pp
Debt / equity0.3×+0.2×
Current ratio0.9×-0.9×

Where this comes from

Reported directly by Chemed in its filing.

Tagged under the XBRL concept us-gaap:DeferredCompensationPlanAssets.

The official record: Chemed’s 10-Q, filed April 28, 2026, on SEC EDGAR. View the filing →

Ask your AI about Chemed's deferred compensation plan assets.

Connect your AI assistant and see it in context, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Chemed's deferred compensation plan assets?
Chemed (CHE) reported deferred compensation plan assets of $143.78M in Q1 2026.
How has Chemed's deferred compensation plan assets changed year-over-year?
Chemed's deferred compensation plan assets increased by 12.4% year-over-year, from $127.95M to $143.78M.
What is the long-term trend for Chemed's deferred compensation plan assets?
Over 5 years (2020 to 2025), Chemed's deferred compensation plan assets has grown at a 9.6% compound annual growth rate (CAGR), from $88.81M to $140.35M.